118 related articles for article (PubMed ID: 38290668)
1. GAS5 promotes cytarabine induced myelosuppression via inhibition of hematopoietic stem cell differentiation.
Du YX; Yang J; Yan H; Liu YL; Chen XP
Toxicol Appl Pharmacol; 2024 Feb; 483():116841. PubMed ID: 38290668
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
Zhao C; Du F; Zhao Y; Wang S; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
[TBL] [Abstract][Full Text] [Related]
3. [Effect of intermediate-dose cytarabine on mobilization of peripheral blood hematopoietic stem cell in acute myeloid leukemia].
Xie M; Zhang Y; Dai M; Wei Q; Li X; Wei Y; Huang F; Fan Z; Jiang Q; Liu Q; Sun J; Feng R
Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):587-91. PubMed ID: 25052597
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution.
Yan H; Zhang DY; Li X; Yuan XQ; Yang YL; Zhu KW; Zeng H; Li XL; Cao S; Zhou HH; Zhang W; Chen XP
Leuk Lymphoma; 2017 Aug; 58(8):1948-1957. PubMed ID: 27951730
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the serum panel reactive antibody on proliferation and differentiation of cord blood CD34+ cells in vitro].
Yang XG; Fang JP; Wu YF; Weng WJ; Xu HG; Xu LH
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):831-5. PubMed ID: 19099900
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.
Jäger P; Geyh S; Twarock S; Cadeddu RP; Rabes P; Koch A; Maus U; Hesper T; Zilkens C; Rautenberg C; Bormann F; Köhrer K; Petzsch P; Wieczorek D; Betz B; Surowy H; Hildebrandt B; Germing U; Kobbe G; Haas R; Schroeder T
Stem Cells; 2021 Sep; 39(9):1270-1284. PubMed ID: 34013984
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
[TBL] [Abstract][Full Text] [Related]
8. Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cells.
Muus P; Haanen C; Raijmakers R; de Witte T; Salden M; Wessels J
Semin Oncol; 1987 Jun; 14(2 Suppl 1):238-44. PubMed ID: 3473679
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
[TBL] [Abstract][Full Text] [Related]
10. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
11. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.
Kadekar D; Kale V; Limaye L
Stem Cell Res Ther; 2015 Oct; 6():201. PubMed ID: 26481144
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT; Zander A
Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
[TBL] [Abstract][Full Text] [Related]
13. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
Bhalla K; Holladay C; Arlin Z; Grant S; Ibrado AM; Jasiok M
Blood; 1991 Nov; 78(10):2674-9. PubMed ID: 1824260
[TBL] [Abstract][Full Text] [Related]
14. Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma.
Bogucka-Fedorczuk A; Czyz A; Kalicińska E; Sawicki M; Laszkowska-Lewko M; Wicherska-Pawłowska K; Rybka J; Szeremet A; Prajs I; Szymczak D; Wróbel T
J Clin Apher; 2020 Aug; 35(4):246-254. PubMed ID: 32298020
[TBL] [Abstract][Full Text] [Related]
15. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
[TBL] [Abstract][Full Text] [Related]
16. Retroviral transfer of the recombinant human erythropoietin receptor gene into single hematopoietic stem/progenitor cells from human cord blood increases the number of erythropoietin-dependent erythroid colonies.
Lu L; Ge Y; Li ZH; Keeble W; Kabat D; Bagby GC; Broxmeyer HE; Hoatlin ME
Blood; 1996 Jan; 87(2):525-34. PubMed ID: 8555474
[TBL] [Abstract][Full Text] [Related]
17. pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.
Bhalla K; Ibrado AM; Bradt JE; Ray S; Huang Y; Tang C; Nawabi A; Hoffman R
Leukemia; 1995 Nov; 9(11):1851-6. PubMed ID: 7475274
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cytotoxicity and differentiation-inducing potential of arabinofuranosylcytosine in myeloid leukemia cells by hematopoietic cytokines.
Brach MA; Mertelsmann RH; Herrmann F
Cancer Invest; 1993; 11(2):198-211. PubMed ID: 8462021
[TBL] [Abstract][Full Text] [Related]
20. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.
Abraham A; Varatharajan S; Karathedath S; Philip C; Lakshmi KM; Jayavelu AK; Mohanan E; Janet NB; Srivastava VM; Shaji RV; Zhang W; Abraham A; Viswabandya A; George B; Chandy M; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2015 Jul; 16(8):877-90. PubMed ID: 26083014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
